Effects of melatonin on plasma S-nitrosoglutathione and glutathione in streptozotocin-treated rats

J Toxicol Environ Health A. 2004 Jul 9;67(13):979-86. doi: 10.1080/15287390490447278.

Abstract

The aim of this study was to determine the effects of streptozotocin-induced diabetes on plasma reduced glutathione (GSH) and S-nitrosoglutathione (GSNO) levels. Further, the study investigated whether an antioxidant, pineal hormone melatonin, could protect against STZ-induced effects. STZ significantly decreased plasma GSH but increased the levels of plasma GSNO. Daily supplementation with melatonin restored plasma thiol to control values. Data suggest that STZ-induced hyperglycemia and compounds that act as scavengers of free radicals and peroxynitrite like melatonin may exert protection against STZ-induced toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / drug therapy*
  • Dietary Supplements*
  • Glutathione / blood*
  • Male
  • Melatonin / administration & dosage
  • Melatonin / pharmacology*
  • Melatonin / therapeutic use
  • Rats
  • Rats, Wistar
  • S-Nitrosoglutathione / blood*
  • Streptozocin

Substances

  • Antioxidants
  • S-Nitrosoglutathione
  • Streptozocin
  • Glutathione
  • Melatonin